Identification of in vitro (rat liver postmitochondrial S9 fraction) metabolites of the antiprotozoal agent 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazole
β Scribed by W. J. A. Vandenheuvel; H. Skeggs; B. H. Arison; P. G. Wislocki
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 369 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The imidazobenzodiazepine derivate 123 I-labelled 3-(5-cyclopropyl-1,2,4-oxadiazo-3-yl)-7-iodo-5,6-dihydro-5methyl-6-oxo-4H-imidazo [1,5-a][1,4]-benzodiazepine (NNC 13Β±8241) is a partial benzodiazepine agonist and binds with a high anity to the benzodiazepine receptor. The favourable kinetic propert
The metabolism of SCH 40120, which is the clinically effective antipsoriatic drug 10- (3chlorophenyl)-6,8,9,10-tetrahydrobenzol[b][1,8]naphthyridin-5(7H)-one, was determined in vitro. Rat, dog, cynomolgus monkey, and human liver slices hydroxylated the aliphatic, cyclohexenyl ring of the drug and co